Altimmune Inc (GB:0A4C)

Altimmune (0A4C) Income Statement


Altimmune Income Statement

Last quarter (Q2 2023), Altimmune's total revenue was $6.00K, a decrease of -25.00% from the same quarter last year. In Q2, Altimmune's net income was $-16.06M. See Altimmune’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ -81.00K$ -68.00K$ 4.41M$ 8.19M$ 5.80M$ 10.33M
Cost of Revenue
Gross Profit
$ -83.00K$ -68.00K----
Operating Expense
$ 41.56M$ -87.67M$ 89.95M$ 62.98M$ 26.27M$ 28.22M
Operating Income
$ -87.61M$ -87.74M$ -85.54M$ -54.80M$ -20.46M$ -17.89M
Net Non Operating Interest Income Expense
$ 6.14M$ 2.86M$ 197.09K$ 313.09K$ 841.16K$ -70.49K
Other Income Expense
$ 135.00K$ 32.00K$ -11.74M$ 24.15K$ -954.86K$ -27.36M
Pretax Income
$ -81.51M$ -84.91M$ -97.09M$ -54.46M$ -20.58M$ -45.32M
Tax Provision
$ -194.00K$ -197.00K$ 0.00$ -5.42M$ -58.50K$ -6.15M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -81.31M$ -84.71M$ -97.09M$ -49.04M$ -20.97M$ -42.48M
Basic EPS
$ -1.67$ -1.81$ -2.35$ -1.91$ -1.60$ -15.16
Diluted EPS
$ -1.66$ -1.81$ -2.35$ -1.91$ -1.60$ -15.16
Basic Average Shares
$ 197.03M$ 46.93M$ 41.28M$ 25.64M$ 13.12M$ 2.80M
Diluted Average Shares
$ 197.03M$ 46.93M$ 41.28M$ 25.64M$ 13.12M$ 2.80M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 41.56M$ -87.67M$ 89.95M$ 62.98M$ 26.27M$ 28.22M
Net Income From Continuing And Discontinued Operation
$ -81.31M$ -84.71M$ -97.09M$ -49.04M$ -20.52M$ -39.17M
Normalized Income
$ -36.20M-$ -85.72M$ -49.04M$ -19.55M$ -15.29M
Interest Expense
$ 64.00K-$ 5.66K$ 9.42K$ 2.24K$ 297.09K
$ -84.76M$ -84.90M$ -97.09M$ -54.45M$ -20.58M$ -45.02M
$ -84.79M$ -84.90M$ -96.53M$ -54.02M$ -20.19M$ -44.72M
Currency in USD

Altimmune Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis